ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation

Recruiting now

Conditions studied: Tricuspid Regurgitation, Heart Failure, Valve Heart Disease

In brief

The goal of this observational study is to characterize the population of patients qualified for transcatheter tricuspid valve interventions (TTVI). It is expected to: * Describe the profile of patients qualified for TTVI * Establish the most common causes for disqualification from TTVI * Evaluate the immediate and long-term efficacy of TTVI * Evaluate TTVI safety Participants will undergo a standard qualification procedure for TTVI and then will be subject to a follow-up consisting of clinical examination, echocardiography and laboratory testing.

Key facts

Study ID

NCT06838611

Run by

Medical University of Warsaw

People needed

300

Starts

2023-11-14

Expected to finish

2028-07-01

Last updated by the study team

2025-02-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• tricuspid regurgitation
• qualification for transcatheter tricuspid valve intervention

You may not qualify if…

• tricuspid regurgitation qualified for surgical treatment
• concomitant left heart valve disease qualified for surgical treatment
• multivessel coronary artery disease qualified for coronary artery bypass grafting
• lack of patient's consent to enter the registry

Where it is running

• First Department of Cardiology, Medical University of Warsaw — Warsaw, Masovian Voivodeship, Poland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.